Janus Henderson Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$799K Buy
+49,331
New +$787K ﹤0.01% 1879
2026
Q1
$11.2M Buy
757,435
+66,806
+10% +$976K 0.01% 729
2025
Q4
$11M Sell
690,629
-350,492
-34% -$4.97M ﹤0.01% 730
2025
Q3
$11.5M Buy
1,041,121
+819,585
+370% +$8.95M 0.01% 721
2025
Q2
$1.88M Buy
221,536
+172,205
+349% +$1.38M ﹤0.01% 1314
2025
Q1
$409K Hold
49,331
– – ﹤0.01% 2058
2024
Q4
$443K Hold
49,331
– – ﹤0.01% 2091
2024
Q3
$361K Hold
49,331
– – ﹤0.01% 2179
2024
Q2
$281K Hold
49,331
– – ﹤0.01% 2238
2024
Q1
$247K Hold
49,331
– – ﹤0.01% 2319
2023
Q4
$444K Hold
49,331
– – ﹤0.01% 2046
2023
Q3
$383K Hold
49,331
– – ﹤0.01% 2074
2023
Q2
$478K Hold
49,331
– – ﹤0.01% 2002
2023
Q1
$540K Buy
49,331
+29,619
+150% +$261K ﹤0.01% 1970
2022
Q4
$85.3K Hold
19,712
– – ﹤0.01% 2360
2022
Q3
$148K Hold
19,712
– – ﹤0.01% 1963
2022
Q2
$198K Hold
19,712
– – ﹤0.01% 2313
2022
Q1
$244K Hold
19,712
– – ﹤0.01% 2343
2021
Q4
$451K Buy
+19,712
New +$467K ﹤0.01% 1953

Other funds holding AUPH

Janus Henderson Group's AUPH Position: Q3 2026 in Review

Janus Henderson Group opened a new position in Aurinia Pharmaceuticals (AUPH) in Q3 2026: 49,331 shares worth $799K. The stake represents ﹤0.01% of the portfolio and ranks #1879 among its holdings. This is a return to the name: Janus Henderson Group previously reported a position in AUPH as recently as Q1 2026.

Janus Henderson Group first reported a position in AUPH in Q4 2021 and has held it in 19 quarters since. The position peaked at $11.5M in Q3 2025. 277 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • Janus Henderson Group held 49,331 shares of Aurinia Pharmaceuticals worth $799K as of Q3 2026.
  • Aurinia Pharmaceuticals was a new Janus Henderson Group position in Q3 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Janus Henderson Group's portfolio in Q3 2026, its #1879 holding.
  • Janus Henderson Group first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Janus Henderson Group's Aurinia Pharmaceuticals position peaked at $11.5M in Q3 2025.
  • 277 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.